These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33484420)

  • 1. Isolated mitochondrial myopathy due to m.3243A > G mutation in MT-TL1 gene.
    Mahale RR; Gautham J; Mailankody P; Padmanabha H; Mathuranath PS
    Acta Neurol Belg; 2022 Aug; 122(4):1115-1116. PubMed ID: 33484420
    [No Abstract]   [Full Text] [Related]  

  • 2. Impediments to Heart Transplantation in Adults With MELAS
    Di Toro A; Urtis M; Narula N; Giuliani L; Grasso M; Pasotti M; Pellegrini C; Serio A; Pilotto A; Antoniazzi E; Rampino T; Magrassi L; Valentini A; Cavallini A; Scelsi L; Ghio S; Abelli M; Olivotto I; Porcu M; Gavazzi A; Kodama T; Arbustini E
    J Am Coll Cardiol; 2022 Oct; 80(15):1431-1443. PubMed ID: 36202533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection rates and phenotypic spectrum of m.3243A>G in the MT-TL1 gene: a molecular diagnostic laboratory perspective.
    Chin J; Marotta R; Chiotis M; Allan EH; Collins SJ
    Mitochondrion; 2014 Jul; 17():34-41. PubMed ID: 24846800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA mutation "m.3243A>G"-Heterogeneous clinical picture for cardiologists ("m.3243A>G": A phenotypic chameleon).
    Niedermayr K; Pölzl G; Scholl-Bürgi S; Fauth C; Schweigmann U; Haberlandt E; Albrecht U; Zlamy M; Sperl W; Mayr JA; Karall D
    Congenit Heart Dis; 2018 Sep; 13(5):671-677. PubMed ID: 30133155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation.
    Esterhuizen K; Lindeque JZ; Mason S; van der Westhuizen FH; Rodenburg RJ; de Laat P; Smeitink JAM; Janssen MCH; Louw R
    Metabolomics; 2021 Jan; 17(1):10. PubMed ID: 33438095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent origin for m.3243A>G mitochondrial mutation in three Venezuelan cases of MELAS syndrome.
    Florez I; Pirrone I; Casique L; Domínguez CL; Mahfoud A; Rodríguez T; Rodríguez D; De Lucca M; Ramírez JL
    Clin Biochem; 2022; 109-110():98-101. PubMed ID: 36130631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multisystem Mitochondrial Disease Caused by a Novel MT-TL1 mtDNA Variant: A Case Report.
    Giannese D; Montano V; Lopriore P; Nesti C; LoGerfo A; Caligo MA; Dal Canto F; Pasquinelli G; Bonadio AG; Moriconi D; Siciliano G; Mancuso M
    J Neuromuscul Dis; 2023; 10(1):119-123. PubMed ID: 36404555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the MELAS m.3243A>G mutation with myositis and the superiority of urine over muscle, blood and hair for mutation detection.
    Marotta R; Reardon K; McKelvie PA; Chiotis M; Chin J; Cook M; Collins SJ
    J Clin Neurosci; 2009 Sep; 16(9):1223-5. PubMed ID: 19502062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Variant of MELAS Syndrome With Executive Dysfunction, Heteroplasmic Point Mutation in the
    Endres D; Süß P; Maier SJ; Friedel E; Nickel K; Ziegler C; Fiebich BL; Glocker FX; Stock F; Egger K; Lange T; Dacko M; Venhoff N; Erny D; Doostkam S; Komlosi K; Domschke K; Tebartz van Elst L
    Front Immunol; 2019; 10():412. PubMed ID: 30949164
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolated cytochrome c oxidase deficiency as a cause of MELAS.
    Rossmanith W; Freilinger M; Roka J; Raffelsberger T; Moser-Thier K; Prayer D; Bernert G; Bittner RE
    J Med Genet; 2008 Feb; 45(2):117-21. PubMed ID: 18245391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation of m.3243A>G (MT-TL1; tRNALeu) variant with focal neurology in infancy.
    Mordaunt DA; McIntyre LC; Salvemini H; Ibrahim A; Bratkovic D; Ketteridge D; Scott HS; Kassahn KS; Smith N
    Am J Med Genet A; 2015 Nov; 167A(11):2697-701. PubMed ID: 26289840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria.
    Karicheva OZ; Kolesnikova OA; Schirtz T; Vysokikh MY; Mager-Heckel AM; Lombès A; Boucheham A; Krasheninnikov IA; Martin RP; Entelis N; Tarassov I
    Nucleic Acids Res; 2011 Oct; 39(18):8173-86. PubMed ID: 21724600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.
    Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA m.3243A>G mutation rarely causes CADASIL-like phenotype.
    Liao NY; Liao KK; Liao YC; Lee YC
    Neurobiol Aging; 2021 Jan; 97():145.e5-145.e6. PubMed ID: 32950272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fulminant cerebral venous thrombosis associated with the m.3243A>G MELAS mutation: A new guise for an old disease.
    Nikolaus M; Tietze A; Schweizer L; Kaindl AM; Stenzel W; Schuelke M; Knierim E
    Brain Dev; 2019 Nov; 41(10):901-904. PubMed ID: 31345444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of myopathic findings in 50 patients with the 3243A>G mutation in mitochondrial DNA.
    Kärppä M; Herva R; Moslemi AR; Oldfors A; Kakko S; Majamaa K
    Brain; 2005 Aug; 128(Pt 8):1861-9. PubMed ID: 15857931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic symptoms in carriers of the m.3243A>G mitochondrial DNA mutation.
    Parsons T; Weimer L; Engelstad K; Linker A; Battista V; Wei Y; Hirano M; Dimauro S; De Vivo DC; Kaufmann P
    Arch Neurol; 2010 Aug; 67(8):976-9. PubMed ID: 20697048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
    El-Hattab AW; Adesina AM; Jones J; Scaglia F
    Mol Genet Metab; 2015; 116(1-2):4-12. PubMed ID: 26095523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MELAS mutation m.3243A>G alters the expression of mitochondrial tRNA fragments.
    Meseguer S; Navarro-González C; Panadero J; Villarroya M; Boutoual R; Sánchez-Alcázar JA; Armengod ME
    Biochim Biophys Acta Mol Cell Res; 2019 Sep; 1866(9):1433-1449. PubMed ID: 31195049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone and Deoxyribonucleoside Combination Treatment Increases Mitochondrial Respiratory Capacity in m.3243A>G MELAS Cybrid Cells.
    Burgin HJ; Lopez Sanchez MIG; Smith CM; Trounce IA; McKenzie M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.